The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorJagiellonian University

About this trial

Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18-70

treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence

Disqualifiers

prolonged thromboprophylaxis

planned surgery other than due to urine incontinence/uterine prolapse

acquired or congenital thrombophilia

Trial population

Women with diagnosed uterine prolapse or urine incontinence after failure of pharmacotherapy.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • determination of fibrin clot properties

    Diagnostic test

    Determination of fibre clot properties and thrombin generation in women with uterine prolapse/ urine incontinence before and after urogynecological surgery.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Women with urine incontinence/ uterine prolapse1 intervention

Trial outcomes

Primary outcomes

1

fibrin clot phenotype

fibrin clot permeability and susceptibility to lysis

Time frame
December 2025 till May 2026
2

Thrombin generation

Endogenous thrombin generation

Time frame
December 2025 till May 2026

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.